Comment: spironolactone prevents amphotericin B-induced hypokalemia in neutropenic patients.
Ural
A U
AU
D000666:Amphotericin B / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced / Q000517:prevention & control*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use*; D009503:Neutropenia / Q000150:complications*; D011188:Potassium / Q000008:administration & dosage / Q000627:therapeutic use; D013148:Spironolactone / Q000627:therapeutic use*
D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000666:Amphotericin B; D011188:Potassium